Back to Search
LAURA ADAM, M.D.
M.D.
Family Medicine Physician
NPI: 1619318532IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
A136805(CA)275039(MA)35.152317(OH)
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
35.152317(OH)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
WRIGHT STATE UNIVERSITY BOONSHOFT SCHOOL OF MEDICINE
Class of 2013
Research & Publications (20)
ADAM10 as a therapeutic target for cancer and inflammation.
PMID 19601831·Curr Pharm Des·2009
6-review
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
PMID 19671845·Clin Cancer Res·2009
4-observational
Relaxation of NH(a(1)Delta, v = 1) in collisions with H((2)S): an experimental and theoretical study.
PMID 19569615·J Phys Chem A·2009
8-other
Thyroid hormone receptor alpha1 follows a cooperative CRM1/calreticulin-mediated nuclear export pathway.
PMID 18641393·J Biol Chem·2008
7-preclinical
Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism.
PMID 18335277·World J Surg·2008
8-other
2-Arylbenzoxazoles as novel cholesteryl ester transfer protein inhibitors: optimization via array synthesis.
PMID 18374566·Bioorg Med Chem Lett·2008
8-other
The Nuclear Factor Y subunits NF-YB2 and NF-YB3 play additive roles in the promotion of flowering by inductive long-day photoperiods in Arabidopsis.
PMID 18600346·Planta·2008
8-other
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
PMID 18316572·Clin Cancer Res·2008
7-preclinical
Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.
PMID 18829495·Clin Cancer Res·2008
8-other
Design and SAR of selective T-type calcium channel antagonists containing a biaryl sulfonamide core.
PMID 18160281·Bioorg Med Chem Lett·2008
7-preclinical
Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer.
PMID 18006009·J Urol·2008
8-other
Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?
PMID 18639280·J Urol·2008
7-preclinical
Rove beetles (Coleoptera: Staphylinidae) collected during the long term ecological research in a Hungarian oak forest.
PMID 18831387·J Environ Biol·2008
7-preclinical
Erosion of the Nuss bar into the internal mammary artery 4 months after minimally invasive repair of pectus excavatum.
PMID 18280298·J Pediatr Surg·2008
5-case
Complex disorder in beta-NH(4)Fe(2)(PO(4))(2): deciphering from a five-dimensional formalism.
PMID 17641420·Acta Crystallogr B·2007
8-other
Molecular correlates of gefitinib responsiveness in human bladder cancer cells.
PMID 17237287·Mol Cancer Ther·2007
7-preclinical
Exploring Renner-Teller induced quenching in the reaction H(2S)+NH(a 1Delta): a combined experimental and theoretical study.
PMID 17249868·J Chem Phys·2007
8-other
Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.
PMID 17308080·Cancer Res·2007
8-other
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
PMID 17437845·J Urol·2007
7-preclinical
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP).
PMID 17502136·Bioorg Med Chem Lett·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2145 N FAIRFILED RD, STE 100
BEAVERCREEK, OH 45431 - Phone
- (937) 558-3900
Quick Facts
- NPI
- 1619318532
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile